|
Press Releases |
|
|
|
Friday, October 25, 2024 |
|
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 |
HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, will present at the American Association for the Study of Liver Diseases' (AASLD) The Liver Meeting, taking place from November 15-19, 2024 in San Diego, California. more info >> |
|
Monday, September 16, 2024 |
|
君聖泰醫藥亮相香港國際生物科技論壇 |
由香港生物科技協會、中國生物工程學會等機構聯合主辦的第三届香港國際生物科技論壇暨展覽BIOHK2024于2024年9月11日-14日在中國香港隆重召開。 more info >> |
|
Tuesday, September 17, 2024 |
|
君聖泰醫藥亮相香港國際生物科技論壇 |
more info >> |
|
Friday, September 13, 2024 |
|
君圣泰医药亮相香港国际生物科技论坛 |
由香港生物科技协会、中国生物工程学会等机构联合主办的第三届香港国际生物科技论坛暨展览BIOHK2024于2024年9月11日-14日在中国香港隆重召开。 more info >> |
|
Wednesday, September 11, 2024 |
|
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱(HTD1801)在T2DM中的两项事后分析 |
君圣泰医药(股票代码: 2511.HK),一家专注于开发多功能创新疗法以解决慢性肝病和代谢性疾病未满足临床需求的医药公司,在第60届欧洲糖尿病研究协会(EASD)年会上发布两项研究成果,展示熊去氧胆小檗碱(HTD1801)作为对靶向肠-肝系统的抗炎及代谢调节剂,在2型糖尿病(T2DM)患者中完成的二项临床2期试验的事后分析结果。 more info >> |
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) |
HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, presents at the 60th European Association for the Study of Diabetes (EASD) Annual Meeting, taking place from September 10-13, 2024 in Madrid, Spain. more info >> |
|
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱(HTD1801)在T2DM中的兩項事後分析 |
君圣泰医药(股票代码: 2511.HK),一家专注于开发多功能创新疗法以解决慢性肝病和代谢性疾病未满足临床需求的医药公司,在第60届欧洲糖尿病研究协会(EASD)年会上发布两项研究成果,展示熊去氧胆小檗碱(HTD1801)作为对靶向肠-肝系统的抗炎及代谢调节剂,在2型糖尿病(T2DM)患者中完成的二项临床2期试验的事后分析结果。 more info >> |
|
Monday, August 12, 2024 |
|
2024 CSE - 君聖泰醫藥分享天然產物在代謝性疾病的創新成果 |
2024年8月7-10日,由中華醫學會、中華醫學會內分泌學分會主辦,江蘇省醫學會承辦的中華醫學會第二十一次內分泌學學術會議在蘇州召開。 more info >> |
|
2024 CSE | 君圣泰医药分享天然产物在代谢性疾病的创新成果 |
2024年8月7-10日,由中华医学会、中华医学会内分泌学分会主办,江苏省医学会承办的中华医学会第二十一次内分泌学学术会议在苏州召开。 more info >> |
|
Monday, July 1, 2024 |
|
河套科創區攜手13家創新企業 君聖泰醫藥協助創新藥國際化發展 |
在深化創新驅動、促進深港協同發展的大背景下,河套科技創新合作區近日成功舉行了一場聚焦全球視野的簽約儀式,引入了包括君聖泰醫藥在內的13家行業領導者。君聖泰醫藥創辦人兼執行長劉利平博士出席儀式並發表致辭,為河套科創的國際合作與創新發展增添了新動力。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 21, 2024 23:34 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 21, 2024 23:23 HKT/SGT
|
|
|
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 21:59 HKT/SGT
|
|
|
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry
Nov 21, 2024 21:29 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 21, 2024 21:20 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 21:00: JST
|
|
|
Yahoo Finance Invest Asia 2024 - Disrupting Finance: Innovations Shaping The Future
Nov 21, 2024 20:45 HKT/SGT
|
|
|
BIP Asia Forum and Entrepreneur Day Returns in December
Nov 21, 2024 20:30 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 20:19 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 21, 2024 19:51 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 21, 2024 19:33 HKT/SGT
|
|
|
SGX-Listed Mooreast Appoints Norwegian Eirik Ellingsen as CEO to Drive Growth in Global Floating Offshore Wind Market
Nov 21, 2024 19:00 HKT/SGT
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 21, 2024 17:54 HKT/SGT
|
|
|
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
|
|
|
TGL Presented by SoFi Names SYNLawn As Official Synthetic Surface Partner, Providing 31,000 Square Feet of Turf for SoFi Center's Tech-Infused Field of Play
Nov 21, 2024 08:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|